
UnitedHealth Group, Hims & Hers Health, and Johnson & Johnson are the three Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of publicly traded companies involved in medical products and services, including pharmaceuticals, biotechnology, medical devices, diagnostics, hospitals, and health insurers. Investors view the sector as driven by regulatory approvals, clinical trial results, patent and reimbursement dynamics, and demographic trends, which can produce both higher volatility and long‑term growth opportunities. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Read Our Latest Research Report on HIMS
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Read Our Latest Research Report on JNJ
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in January 2026
- 3 Retailers at 52-Week Highs With More Room to Run
- 3 Strong Dividend Growers for Income Without Rate Risk
- This ETF Is Up 146% as the Battle Over Rare Earths Heats Up
- D-Wave’s Year in Review: 2025 Wins Set the Stage for 2026
- Meta’s New AI Glasses See “Unprecedented Demand”—What’s Next?
